Story excerpt provided by Crain’s Cleveland Business.
GenomOncology, a Cleveland, Ohio company that has developed a technology platform to streamline the use of next-generation sequencing data in medical care and research, said it has named Dr. Joshua F. Coleman as vice president of medical affairs. Coleman “will oversee clinical content development and curation of scientific evidence, enhancing the company’s proprietary knowledge-enabled platform,” GenomOncology said in a news release.
Click here to read the complete article.
Originally published November 30, 2016.